keynote speaker: understanding the monitoring and safety of ibd medications and biologics
Published 5 years ago • 2.1K plays • Length 32:29Download video MP4
Download video MP3
Similar videos
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
27:04
keynote speaker: what will be the exciting clinical challenges in ibd in 2019?
-
20:40
role of disease monitoring in ibd
-
31:25
keynote speaker: the environment and ibd: what every patient asks and every clinician should
-
21:14
when and how to use immunomodulators and biologics in ibd
-
25:33
understanding the mechanisms of action of new agents: implications for efficacy and safety
-
29:32
keynote speaker: what will it take to develop the cures for ulcerative colitis and crohn's disease
-
21:36
keynote: evolution of disease management in ibd
-
21:30
ibd: beyond combination therapy
-
22:05
understanding the use of il12/il23 targeted biologics
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
20:47
positioning inhibitors of lymphocyte trafficking
-
12:48
ibd clinical update: new and emerging targeted therapies
-
28:12
current and evolving therapeutic landscape of ibd
-
29:01
case discussion ii: the biologically-experienced ibd patient
-
12:58
positioning of biologics and new therapeutics for crohn's disease
-
26:10
recent and emerging ulcerative colitis therapies
-
21:36
how will future therapeutic pathways change for ulcerative colitis and crohn's disease?
-
26:49
update on the therapeutic drug monitoring in ibd: for use in situations other than loss of response?